Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Vaccines
New vaccines study findings have been published by T. Mizukami and colleagues
April 15th, 2009
"Vaccines differ from other pharmaceutical products. The quality and safety of batches are regulated to high standards by national regulatory authorities," scientists in Tokyo, Japan report. "Various quality control and safety tests have been developed, including the abnormal toxicity test (ATT), which is described in the World Health Organization (WHO) guidelines and in each country's pharmacopoeia. However, the criteria for abnormal results are not well defined in these guidelines. In addition, the animal grade to be used in ATT, classified on the basis of microbial colonization, was not designated in either guideline. In this study, we report a new and improved...
Source: Vaccine Weekly (2009-04-15)
|
